Axq Capital, LP Gossamer Bio, Inc. Transaction History

Axq Capital, LP

$261 Billion
Q3 2025

A detailed history of Axq Capital, LP transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Axq Capital, LP holds 46,367 shares of GOSS stock, worth $125,654. This represents 0.05% of its overall portfolio holdings.

Number of Shares

46,367

Holding current value

$125,654

% of portfolio

0.05%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2025 Nov 10, 2025	BUY	$1.21 - $3.46 $56,104 - $160,429	46,367 New	46,367 $122 Million
Q4 2022 Feb 10, 2023	BUY	$1.74 - $12.87 $28,487 - $210,707	16,372 New	16,372 $35.5 Million

Others Institutions Holding GOSS

# of Institutions

179

Shares Held

163M

Call Options Held

8.11M

Put Options Held

211K

Nea Management Company, LLC Timonium, MD

18.1M
Shares

$49 Million
2.97% of portfolio
Octagon Capital Advisors LP New York, NY

17.1M
Shares

$46.2 Million
14.61% of portfolio
Vanguard Group Inc Valley Forge, PA

12M
Shares

$32.5 Million
0.0% of portfolio
Arch Venture Management, LLC Chicago, IL

8.06M
Shares

$21.8 Million
9.24% of portfolio
Samsara Bio Capital, LLC Palo Alto, CA

6.13M
Shares

$16.6 Million
6.11% of portfolio

View Full List

About Gossamer Bio, Inc.

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $255M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

More about GOSS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axq Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Axq Capital, LP with notifications on news.

Account